It is important to note that the exposure of the germline mutation carriers to effects of TET2 loss is life-long and extreme, as compared to the typical CH setting of a minor somatic heterozygous TET2-mutant subclone—2% or higher variant allele frequency39—emerging late in life. Here, TET2 is linked to cyclic hematopoiesis.